News | March 11, 2021
UPM Biomedicals and CELLINK collaborates for 3D bioprinting developments
The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.
